1. Home
  2. ECPG vs ADMA Comparison

ECPG vs ADMA Comparison

Compare ECPG & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encore Capital Group Inc

ECPG

Encore Capital Group Inc

HOLD

Current Price

$89.00

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.66

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECPG
ADMA
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1999
2012

Fundamental Metrics

Financial Performance
Metric
ECPG
ADMA
Price
$89.00
$8.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$77.33
$25.67
AVG Volume (30 Days)
253.1K
3.3M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
287.14
N/A
EPS
3.86
0.19
Revenue
$1,768,802,000.00
$42,219,783.00
Revenue This Year
$4.53
$27.46
Revenue Next Year
$4.76
$22.11
P/E Ratio
$22.64
$45.89
Revenue Growth
34.37
43.85
52 Week Low
$35.68
$7.21
52 Week High
$92.64
$20.46

Technical Indicators

Market Signals
Indicator
ECPG
ADMA
Relative Strength Index (RSI) 71.82 52.30
Support Level $77.69 $7.38
Resistance Level $92.64 $8.90
Average True Range (ATR) 2.68 0.33
MACD 0.73 0.12
Stochastic Oscillator 90.06 67.24

Price Performance

Historical Comparison
ECPG
ADMA

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: